Ye Hong, Huang Guo-ning, Gao Yang, Liu De Yi
Reproductive and Genetics Institute, Chongqing Obstetrics and Gynecology Hospital, Chongqing, China.
Hum Reprod. 2006 Jun;21(6):1545-50. doi: 10.1093/humrep/del008. Epub 2006 Apr 4.
Sperm-hyaluronan-binding assay (HBA) is one of the commercial kits being marketed for routine testing of sperm maturity and fertility. However, there is no report of whether the HBA can provide additional information over standard semen analysis for sperm-fertilizing ability. The objective of this study was to investigate the relationship between HBA and fertilization rate in conventional IVF.
A total of 175 IVF patients with > or = 3 mature oocytes inseminated were included in the study. Both the standard semen analysis and the HBA were performed on the same ejaculated sperm samples used for IVF treatments. Relationships between the semen analysis and the HBA results and fertilization rate were analysed by both the Spearman test and the multivariate logistic regression analysis.
Both total and progressive sperm motility and normal morphology were highly correlated with HBA scores. While both normal sperm morphology and HBA scores were statistically significantly related to fertilization rates, the HBA was less significant than normal sperm morphology. The HBA does not provide additional information for identifying patients with a poor fertilization rate.
HBA is highly significantly correlated with sperm motility and morphology but is less significant than sperm morphology in relation to the fertilization rate in IVF. Thus, the clinical predictive value of HBA for sperm-fertilizing ability in vitro is limited.
精子-透明质酸结合试验(HBA)是一种用于精子成熟度和生育能力常规检测的商业化试剂盒。然而,尚无关于HBA相对于标准精液分析在精子受精能力方面是否能提供额外信息的报道。本研究的目的是探讨常规体外受精(IVF)中HBA与受精率之间的关系。
本研究共纳入175例接受IVF治疗且有≥3个成熟卵母细胞受精的患者。对用于IVF治疗的同一射精精子样本进行标准精液分析和HBA检测。采用Spearman检验和多因素逻辑回归分析来分析精液分析、HBA结果与受精率之间的关系。
精子总活力、前向运动活力和正常形态均与HBA评分高度相关。虽然正常精子形态和HBA评分均与受精率在统计学上显著相关,但HBA的相关性低于正常精子形态。HBA在识别受精率低的患者方面并不能提供额外信息。
HBA与精子活力和形态高度显著相关,但在IVF受精率方面其相关性低于精子形态。因此,HBA在体外对精子受精能力的临床预测价值有限。